Middle East and Africa PDX Models Market-Industry Trends and Forecast to 2027

  • Healthcare
  • Published Report
  • Jul 2020
  • MEA
  • 350 Pages
  • No of Tables: 127
  • No of Figures: 41

Middle East and Africa PDX Models Market, By Type (Mice Models and Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models and Others), Application (Preclinical Drug Development, Precision Medicine, Co-clinical Trials, Basic Cancer Research & Biomarker Analysis), Technique (Heterotopic Implantation and Orthotropic Implantation), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Organizations and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel and  Rest of Middle East and Africa) Industry Trends & Forecast to 2027      

Middle East and Africa PDX Models MarketMarket Analysis and Insights: Middle East and Africa PDX Models Market

PDX models market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with CAGR of 11.0% in the forecast period of 2020 to 2027 and is expected to reach USD 4,758.98 thousand by 2027. Wide adoption of PDX models in preclinical research & increasing demand for personalized medicine in PDX models are the major drivers which propelled the demand of the market in the forecast period. 

In patient derived xenografts (PDX) models, the cancerous tumor or cells from the patients are transferred/ implanted into the immunodeficient rodents as mice or rat. PDX models are developed for the cancer research on the basis of expectations that these models have the capability to retain the tumor characteristics particularly for the patient derived orthotropic xenograft. Basically these models include the uninterrupted transfer of human disease sample into the mice. 

PDX models are considered as an effective tool in the field of biomedical research, preclinical trials as both the species have similarities and these models have the capability of carrying the characteristics of the tumor, and also allow studying the tumor and its heterogeneity. They help in the evaluation of the tumor growth rate, life cycle of the tumor and growth rate of the tumor in different conditions. They also help in differentiating between the adult and childhood cancer. The adoption of the new therapies, patient specific therapies, and personalized medicine are all established by the use of PDX models in the basic cancer research and drug development.

The PDX models market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Middle East and Africa PDX Models MarketMiddle East and Africa PDX Models Market Scope and Market Size

PDX models market is segmented on the basis of type, tumor type, application, technique and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

  • On the basis of type, the PDX models market is classified into mice models and rat models. Mice models segment is expected to dominate the market as researchers are increasingly using mice models more often than rats, because of mice superiority as genetic models. Further, smaller size of mice does offer some advantages, including requiring lower drug dosages, which makes them more cost-effective in drug development research.    
  • On the basis of tumor type, the PDX models market is classified into gastrointestinal tumor models, lung tumor models, haematological tumor models, gynecological tumor models, respiratory tumor models, urological tumor models and others. Gastrointestinal tumor models is expected to dominate the market as due to increasing number of gastrointestinal tumor models along with increasing gastrointestinal tumor researches in academic & research institutions and contract research organizations.
  • On the basis of application, the PDX models market is classified into preclinical drug development, precision medicine, co-clinical trials, and basic cancer research.  Basic cancer research disease segment is expected to dominate the market due to increasing adoption of PDX Models for basic cancer research.  Basic cancer research is the characterization of cancer biology and to explore mechanisms which is involved for prediction or understanding of cancer. PDX models essentially provide importance in-vivo and ex-vivo evidence to aid basic studies of cancer, including tumor characterization, tumorigenesis, and metastasis. 
  • On the basis of technique, the PDX models market is segmented into heterotopic implantation and orthotropic implantation. Heterotopic implantation segment is expected to dominate the market as Heterotopic Implantation offers various advantages including easy methods of cell implantation, accurate monitoring of tumor size. Subcutaneous and intravenous PDX models, for solid tumors and leukemia, respectively, are most widely used in cancer research. Moreover, heterotopic implantation is less technically challenging and time-consuming as compared to orthotropic implantation.  
  • On the basis of end user, the PDX models market is segmented into academic & research organizations, contract research organizations, pharmaceutical and biotechnological companies and others. Academic & research institutions segment is expected to dominate the market as the PDX models usage are continuously increasing in academic & research institutions for basic cancer research particularly for characterization of cancer biology, tumorigenesis and metastasis.  

Middle East and Africa PDX Models Market Country Level Analysis

The PDX models market is analysed and market size information is provided by country, type, tumor type, application, technique and end user.    

The countries covered in Middle East and Africa PDX models market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel and  rest of Middle East and Africa.     

Saudi Africa is dominating the Middle East and Africa market with the increase in adoption of PDX models in preclinical research and also increasing R and D activities in the pharmaceutical industries.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Increase in Research and Development Activities are Creating New Opportunities for Players in the PDX Models Market 

PDX models market also provides you with detailed market analysis for every country growth in aesthetic industry with PDX models sales, impact of advancement in the PDX models and changes in regulatory scenarios with their support for the PDX models market. The data is available for historic period 2010 to 2018.  

Competitive Landscape and PDX Models Market Share Analysis

PDX models market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to PDX models market. 

The major players covered in the report are Covance In., Horizon Discovery Ltd., Wuxi AppTec, among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.      

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the PDX models market.

For instance,

  • In March 2018, Labcorp officially announced a statement that its segment Covance Drug development for Covance Inc. was dedicated to needs of drug development for the advancements of new therapies and drugs which could enhance the segment and the player could now be able to serve more healthcare professionals across the world.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the PDX models market which also provides the benefit for organisation to improve their offering for PDX models.

Customization Available: Middle East and Africa PDX Models Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 HOST MOUSE STRAINS USED BY INSTITUTION

TABLE 2 PDX MODELS USED TO EVALUATE VARIOUS NEW DRUGS & TARGET

TABLE 3 PDX MODELS USED FOR PANCREATIC CANCER WITH INCREASE IN SUCCESSION RATE

TABLE 4 PDX SERVICE

TABLE 5 PDX TAKE-RATE FROM TUMOUR TISSUE IMPLANTATIONS

TABLE 6 CANCER TECHNOLOGY PROJECT AWARDED CANCER MOONSHOT FUNDING

TABLE 7 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 8 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 9 MIDDLE EAST & AFRICA MICE MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 10 MIDDLE EAST & AFRICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 11 MIDDLE EAST & AFRICA RAT MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 12 MIDDLE EAST & AFRICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 13 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 14 MIDDLE EAST & AFRICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 15 MIDDLE EAST & AFRICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 16 MIDDLE EAST & AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 17 MIDDLE EAST & AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 18 MIDDLE EAST & AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 19 MIDDLE EAST & AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 20 MIDDLE EAST & AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 21 MIDDLE EAST & AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 22 MIDDLE EAST & AFRICA RESPIRATORY TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 23 MIDDLE EAST & AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 24 MIDDLE EAST & AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 25 MIDDLE EAST & AFRICA OTHERS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 26 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 27 MIDDLE EAST & AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 28 MIDDLE EAST & AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 29 MIDDLE EAST & AFRICA PRECLINICAL DRUG DEVELOPMENT IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 30 MIDDLE EAST & AFRICA BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 31 MIDDLE EAST & AFRICA CO-CLINICAL TRIALS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 32 MIDDLE EAST & AFRICA PRECISION MEDICINE IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 33 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 34 MIDDLE EAST & AFRICA HETEROTOPIC IMPLANTATION IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 35 MIDDLE EAST & AFRICA ORTHOTOPIC IMPLANTATION IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 36 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 37 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 38 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 39 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 40 MIDDLE EAST & AFRICA OTHERS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 41 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)

TABLE 42 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 43 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 44 MIDDLE EAST & AFRICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 45 MIDDLE EAST & AFRICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 46 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 47 MIDDLE EAST & AFRICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 48 MIDDLE EAST & AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 49 MIDDLE EAST & AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 50 MIDDLE EAST & AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 51 MIDDLE EAST & AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 52 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 53 MIDDLE EAST & AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 54 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 55 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 56 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 57 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 58 SOUTH AFRICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 59 SOUTH AFRICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 60 SOUTH AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 61 SOUTH AFRICA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 62 SOUTH AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 63 SOUTH AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 64 SOUTH AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 65 SOUTH AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 66 SOUTH AFRICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 67 SOUTH AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 68 SOUTH AFRICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 69 SOUTH AFRICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 70 U.A.E. PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 71 U.A.E. PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 72 U.A.E. MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 73 U.A.E. RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 74 U.A.E. PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 75 U.A.E. GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 76 U.A.E. GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 77 U.A.E. LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 78 U.A.E. HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 79 U.A.E. UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 80 U.A.E. PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 81 U.A.E. BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 82 U.A.E. PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 83 U.A.E. PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 84 ISRAEL PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 85 ISRAEL PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 86 ISRAEL MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 87 ISRAEL RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 88 ISRAEL PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 89 ISRAEL GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 90 ISRAEL GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 91 ISRAEL LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 92 ISRAEL HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 93 ISRAEL UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 94 ISRAEL PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 95 ISRAEL BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 96 ISRAEL PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 97 ISRAEL PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 98 SAUDI ARABIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 99 SAUDI ARABIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 100 SAUDI ARABIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 101 SAUDI ARABIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 102 SAUDI ARABIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 103 SAUDI ARABIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 104 SAUDI ARABIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 105 SAUDI ARABIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 106 SAUDI ARABIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 107 SAUDI ARABIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 108 SAUDI ARABIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 109 SAUDI ARABIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 110 SAUDI ARABIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 111 SAUDI ARABIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 112 EGYPT PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 113 EGYPT PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

TABLE 114 EGYPT MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 115 EGYPT RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 116 EGYPT PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 117 EGYPT GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 118 EGYPT GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 119 EGYPT LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 120 EGYPT HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 121 EGYPT UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)

TABLE 122 EGYPT PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 123 EGYPT BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 124 EGYPT PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)

TABLE 125 EGYPT PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 126 REST OF MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 127 REST OF MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions